27240 comments

• Comment Link Samstag, 18 Januar 2025 04:41 posted by https://gridnet.org/wpp/index.php/2021/05/21/hello-world/

  Very good post! We will be linking to this great article on our website.
  Keep up the great writing. https://gridnet.org/wpp/index.php/2021/05/21/hello-world/
• Comment Link Samstag, 18 Januar 2025 04:38 posted by jasa google ads hitam

  Saved as a favorite, I like your website!
• Comment Link Samstag, 18 Januar 2025 04:11 posted by keytamin

  Thanks to my father who informed me on the topic of this blog, this web site is
  actually remarkable.
• Comment Link Samstag, 18 Januar 2025 03:54 posted by View more

  What's up to all, how is the whole thing, I think every one is getting more from this website, and your views are fastidious
  in support of new users.
• Comment Link Samstag, 18 Januar 2025 03:53 posted by https://theterritorian.Com.au/index.php?page=useraction=pub_profileid=590273

  I've been surfing online greater than three hours lately, but I
  never discovered any fascinating article like yours.
  
  It's beautiful worth sufficient for me. Personally, if all web owners and
  bloggers made just right content as you probably did, the net might be a lot
  more useful than ever before. https://theterritorian.Com.au/index.php?page=user&action=pub_profile&id=590273
• Comment Link Samstag, 18 Januar 2025 03:37 posted by giftcardmall.mygift

  Hi there, I found your web site by the use of Google at the same time as searching for a comparable matter, your site came up, it appears to be like great.
  I have bookmarked it in my google bookmarks.
  Hi there, just become alert to your blog through Google, and found that it's really informative.
  I am going to be careful for brussels. I will be grateful when you continue this in future.
  A lot of other folks shall be benefited from your writing.
  
  Cheers!
• Comment Link Samstag, 18 Januar 2025 03:36 posted by cheap oa

  Thanks for sharing your thoughts about lerntherapie. Regards
• Comment Link Samstag, 18 Januar 2025 03:15 posted by Manisa.Ogo.org.tr

  I am genuinely grateful to the holder of this web site who has shared this
  fantastic piece of writing at here. http://manisa.Ogo.org.tr/question/exploring-the-best-magazines-in-canada-a-guide-for-readers-2/
• Comment Link Samstag, 18 Januar 2025 03:14 posted by ナンセンス文学 プロセカ

  Successful day traders in their time don't happen by accident.
• Comment Link Samstag, 18 Januar 2025 02:53 posted by Pgjoker

  By Lewis Krauskopf
  
  NEW YORK, July 13 (Reuters) - Shares of U.S. healthcare companies are gaining favor as investors bank on their ability to
  weather rocky economic times and the stocks look
  more reasonably valued than other defensive sectors.
  
  Healthcare has been the top-performing S&P 500 sector over
  the past month, rising nearly 3% while the broader
  market has fallen modestly. The group has fallen 8.7% so
  far this year, less severe than the nearly 20% drop for
  the benchmark S&P 500 overall.
  
  Strategists at Goldman Sachs, Morgan Stanley and BofA Global Research are among those favoring the healthcare
  sector, given that the companies' businesses are expected to hold up better
  than others should the economy face a downturn.
  
  "We feel like it is one of the last opportunities to play defense at a reasonable price," said Walter Todd, chief investment officer at Greenwood Capital in South Carolina.
  
  
  Greenwood is overweight healthcare stocks in its large-cap portfolios
  including shares of Johnson & Johnson, Thermo
  Fisher Scientific and Pfizer Inc.
  
  How healthcare companies are performing will become more clear
  in the coming days as second-quarter reports roll in, starting on Friday with UnitedHealth Group Inc, the
  largest U.S. healthcare company by market value.
  
  
  Earnings in the healthcare sector - which includes large drugmakers, medical equipment companies,
  health insurers and biotech firms - have outperformed in recent recessionary periods.
  That makes them an attractive target for investors looking for assets that
  can weather a potential downturn, as recession worries
  grow amid aggressive monetary policy tightening from
  the Federal Reserve.
  
  For example, while overall S&P 500 earnings
  fell for nine straight quarters during the Great Recession in 2007-2009, the healthcare sector posted earnings growth in those periods, according to Refinitiv IBES data.
  
  
  Over the last 25 years, earnings per share for the sector have increased nearly 10% annually compared with
  6.6% annual growth for the S&P 500, while producing "much more consistent annual growth relative to the broader market," according to Eric Potoker,
  U.S. healthcare equity strategist in the CIO office of UBS Global Wealth Management.
  
  
  
  "If they have healthcare needs, that is usually one of the last places that people will ration," Potoker said.
  
  
  Healthcare also remains relatively more attractive than other
  so-called defensive stocks based on standard valuation metrics.
  
  
  Healthcare is trading at 15.7 times forward earnings estimates against
  its long-term price-to-earnings average of 17.5 times,
  according to Refinitiv Datastream. That represents
  a 10% discount.
  
  Meanwhile, other defensive sectors are trading at premiums relative to their historical valuations - with utilities at a
  premium of over 30% and consumer staples at a 12% premium.
  
  
  
  Unlike healthcare stocks, utilities and staples, at 19.4 times and 20.1 times, respectively, are also trading above
  the 16.1 times P/E ratio of the overall S&P 500.
  
  
  "We find other traditionally defensive sectors, including utilities and staples, to be expensive relative to the broader market," Tony DeSpirito, chief
  investment officer of U.S. fundamental equities at BlackRock, said in his third-quarter equity outlook in which he described "an underappreciated opportunity in healthcare stocks."
  
  To be sure, should investors become more upbeat about the economy, that could
  lead them to leave behind healthcare shares for more cyclically sensitive stocks such as financials or industrials.
  
  
  
  Healthcare also for years has faced persistent investor concerns about regulatory
  changes, particularly related to potential U.S. action to rein in prescription drug prices, which has created a cloud over the stocks.
  
  
  In the coming months, Democrats in U.S. Congress could try
  to pass a drug-pricing bill, and "biopharma stocks could be volatile if legislation progresses," analysts at SVB Securities said in a note.
  
  
  
  (Reporting by Lewis Krauskopf in New York Editing by Ira
  Iosebashvili and Matthew Lewis)